瑞典全国性胸腹主动脉瘤腔内修复术结局分析
基于瑞典血管登记库2018–2023年数据,分析339例胸腹主动脉瘤患者共476次腔内修复(择期366次、急诊110次)的短期与中期结局。择期患者30天、90天、1年死亡率分别为2.6%、3.5%、12.4%,急诊患者分别为12.5%、17.6%、26.9%;围术期心肌梗死是择期与急诊修复后1年死亡率的最强预测因素。
要点
- 择期腔内修复TAAA的30天死亡率为2.6%,急诊为12.5%。
- 择期与急诊修复后1年死亡率分别为12.4%与26.9%。
- 围术期心肌梗死是择期和急诊修复后1年死亡的最强预测因素。
核心结论
- 瑞典胸腹主动脉瘤腔内修复术并发症率显著,但中期生存可接受。
- 围术期心肌梗死是择期和急诊修复后1年死亡率的最强预测因素。
研究设计与样本
- 基于瑞典血管登记库(Swedvasc)2018–2023年数据的全国性队列分析。
- 共纳入339例胸腹主动脉瘤患者,涉及476次腔内修复(择期366次、急诊110次),分布于11个中心,其中94%集中于5个中心。
主要发现
- 择期患者(235例,平均直径64 mm)30天、90天、1年死亡率分别为2.6%、3.5%、12.4%。
- 择期患者主要并发症、血管并发症和胸腹主动脉危及生命事件(TALE)发生率分别为16.2%、9.8%和14%。
- 急诊患者(104例,平均直径73 mm)30天、90天、1年死亡率分别为12.5%、17.6%、26.9%。
- 急诊患者主要并发症、血管并发症和TALE发生率分别为20.2%、12.5%和24%。
- 择期患者1年和4年Kaplan-Meier生存估计分别为89.3%(标准误2.1%)和73.5%(标准误3.7%);急诊患者分别为75.2%(标准误4.3%)和56.5%(标准误6.2%)。
关键数值与推荐
- 预防性脊髓引流使用率随时间从68%下降至14%,脊髓缺血发生率从20%下降至2.3%。
- 围术期心肌梗死是择期和急诊修复后1年死亡率的最强预测因素。
临床怎么用
- 胸腹主动脉瘤腔内修复需重视围术期心肌梗死的预防与处理。
- 择期与急诊修复的死亡率和并发症率差异显著,应据此进行风险分层与知情沟通。
- 预防性脊髓引流使用减少的同时脊髓缺血发生率下降,提示可选择性地应用该措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complex endovascular repair has emerged as a minimally invasive alternative for thoracoabdominal aortic aneurysms (TAAAs). The aim of this study was to assess the short- and mid-term outcomes of endovascular TAAA repair in Sweden. METHODS: All endovascular TAAA repairs performed during 2018-2023 were identified in the Swedish Vascular (Swedvasc) Registry. Patient characteristics, operative details, and outcomes were analysed. The primary outcome was survival; secondary outcomes included complications and thoracoabdominal aortic life-altering events (TALEs). Predictors of mid-term outcomes were assessed in multivariable analysis. RESULTS: Some 339 patients were treated for TAAAs, which included 476 repairs (366 elective repairs and 110 emergency repairs) across 11 centres (94% concentrated in 5 centres). Elective patients (235 patients; mean diameter 64 mm) had 30-day, 90-day, and 1-year mortality of 2.6%, 3.5%, and 12.4% respectively. Major complications, vascular complications, and TALEs occurred in 16.2%, 9.8%, and 14% respectively. The use of prophylactic spinal drainage declined over time (from 68% to 14%) and the incidence of spinal cord ischaemia declined over time (from 20% to 2.3%). Mean(s.e.) 1-year and 4-year Kaplan-Meier survival estimates were 89.3%(2.1%) and 73.5%(3.7%) respectively. Emergency patients (104 patients; mean diameter 73 mm) had 30-day, 90-day, and 1-year mortality of 12.5%, 17.6%, and 26.9% respectively. Major complications, vascular complications, and TALEs occurred in 20.2%, 12.5%, and 24% respectively. Mean(s.e.) 1-year and 4-year Kaplan-Meier survival estimates were 75.2%(4.3%) and 56.5%(6.2%) respectively. Perioperative myocardial infarction was the strongest predictor of 1-year mortality after both elective and emergency repair. CONCLUSION: Endovascular TAAA repair in Sweden is associated with significant complication rates, but acceptable mid-term survival. Further research should focus on perioperative refinements, especially with regard to preserving organ function. This summary explains the outcomes of endovascular repair for thoracoabdominal aortic aneurysms (TAAAs; that is aortic aneurysms involving both the thorax and the abdomen) in Sweden. Conventional surgery for TAAAs is very challenging, with high risks of death and complications. A newly developed endovascular repair operation provides a less invasive alternative and faster recovery. The goal was to find out the survival and complication rates for endovascular repair of TAAAs in Sweden. The authors identified all patients who underwent endovascular TAAA repair in Sweden from 2018 to 2023, using the Swedish Vascular (Swedvasc) Registry. Elective and emergency patients were put into separate groups. Survival at 30 days, 1 year, and 4 years was analysed. Perioperative complications were also investigated. A total of 339 patients received treatment: 235 patients were treated electively and 104 patients were treated as emergencies. In the elective group, survival at 30 days, 1 year, and 4 years was 97.4%, 87.6%, and 73.5% respectively. The chance of serious complication was 14%. In the emergency group, survival at 30 days, 1 year, and 4 years was 87.5%, 73.1%, and 56.5% respectively. The chance of serious complication was 24%. Endovascular repair for this type of aneurysm in Sweden is associated with good outcomes and acceptable perioperative risk.
引用
- Yu HHY, Asciutto G, Dias NV, et al. Nationwide outcomes of endovascular thoracoabdominal aortic aneurysm repair. Br J Surg. 2026. PMID: 41885956. doi:10.1093/bjs/znag035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。